Data / Form D filings / 2A Biosciences, Inc.
2A Biosciences, Inc.: Form D filings
2A Biosciences, Inc., a pharmaceuticals company in Santa Monica, CA, filed 2 Form D notices with the SEC in 2023. The latest, on July 27, 2023, reports $3.8 million sold of a $5.5 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2A Biosciences, Inc., 1714 BRYN MAWR, Santa Monica, CA, 90405
- Phone
- (917) 757-1051
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1968754
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2023 | Amendment | $5,500,000 | $3,779,777 | $1,720,223 | 13 | Mar 1, 2023 | sec.gov |
| Mar 14, 2023 | New notice | $4,500,000 | $1,337,500 | $3,162,500 | 12 | Mar 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gopal Paul Das | Director | |
| Alexander Speiser | Executive Officer, Director | |
| Charles David Nichols | Executive Officer, Director | |
| Timothy Paul Foster | Director, Executive Officer | |
| David Earl Nichols | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 24, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what 2A Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.